Core Viewpoint - The Trade Desk, Inc. is facing allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, which has led to execution challenges and negatively impacted revenue growth [1][2]. Group 1: Allegations and Impact - The complaint alleges that during the class period from May 9, 2024, to February 12, 2025, The Trade Desk experienced significant execution challenges in rolling out its AI tool, Kokai, transitioning clients from the older platform, Solimar [1]. - These execution challenges delayed the Kokai rollout, which in turn negatively impacted the company's business operations and revenue growth [1]. - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false and misleading [1]. Group 2: Shareholder Actions - Shareholders who purchased shares of TTD during the specified class period are encouraged to register for potential lead plaintiff appointment, with a deadline set for April 21, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. Group 3: Legal Representation - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of FMC Corporation regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from November 16, 2023, to February 4, 2025 [1] Group 1: Allegations - The complaint alleges that FMC's channel management initiatives were not progressing as represented [1] - The company faced pricing pressure and decided not to compete on prices, leading to missed sales opportunities [1] - FMC reportedly inflated inventory in channels across Latin America, Asia, Canada, and Eastern Europe [1] - As a result of these issues, the positive statements made by the defendants about FMC's business and prospects were materially misleading [1] Group 2: Class Action Details - Shareholders who purchased FMC shares during the specified class period are encouraged to register for the class action [2] - The deadline for shareholders to seek lead plaintiff status is April 14, 2025 [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2] Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3]

Core Viewpoint - Newmont Corporation is facing a class action lawsuit due to disappointing financial results and operational challenges, leading to a significant drop in its stock price [1][2]. Group 1: Allegations and Financial Impact - The class period for the lawsuit is from February 22, 2024, to October 23, 2024 [1]. - On October 23, 2024, Newmont announced disappointing EBITDA for Q3 2024, along with decreased production and increased operating costs [1]. - The company revealed that mining operations at its two Tier 1 assets would experience lower production than previously guided, with expectations of higher costs [1]. - Following the announcement, Newmont's stock price fell from $57.74 per share to $49.25 per share, a decline of approximately 14.5% [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 1, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Trade Desk, Inc. is facing allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, which has led to execution challenges and negatively impacted its business operations and revenue growth [1][2]. Allegations Summary - The complaint alleges that during the class period from May 9, 2024, to February 12, 2025, The Trade Desk experienced significant execution challenges in rolling out its AI tool Kokai, including difficulties in transitioning clients from the older platform Solimar [1]. - These execution challenges delayed the rollout of Kokai, which in turn negatively affected the company's business and revenue growth [1]. - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of The Trade Desk during the specified class period are encouraged to register for the class action by April 21, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [2]. Firm's Commitment - The Gross Law Firm is dedicated to protecting the rights of investors affected by deceit and illegal business practices, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Innovative Industrial Properties, Inc. (IIPR) regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from February 27, 2024, to December 19, 2024, IIPR made materially false and misleading statements, failing to disclose significant declines in rent and property-management fees related to certain customer leases [1]. - It is claimed that these issues would likely impair the company's ability to maintain funds from operations and revenue growth [1]. - The leasing operations of IIPR were reportedly less profitable than represented to investors, leading to materially false and misleading public statements [1]. Class Action Details - Shareholders who purchased IIPR shares during the class period are encouraged to register for the class action, with a deadline set for March 18, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by false or misleading statements that led to artificial inflation of stock prices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Micron Technology, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about the demand for its products, particularly in the consumer market for NAND products [1][2]. Group 1: Allegations - The complaint claims that during the class period from September 28, 2023, to December 18, 2024, Micron's management failed to disclose a significant deterioration in demand for its products, especially NAND products [1]. - It is alleged that the company overstated the recovery of demand for its products and the sustainability of that demand, leading to misleading public statements [1]. - The lawsuit asserts that these misleading statements resulted in an artificial inflation of Micron's stock price [3]. Group 2: Class Action Details - Shareholders who purchased shares of Micron during the specified class period are encouraged to register for the class action, with a deadline set for March 10, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - There is no cost or obligation for shareholders to participate in this class action [2].

NEW YORK, Feb. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV).Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/modivcare-inc-loss-submission-form/?id=132340&from=4 CLASS PERIOD: November 3, 2022 to Sep ...

Core Viewpoint - Novo Nordisk A/S faced a significant drop in stock price following the announcement of disappointing results from their "REDEFINE 1" trial, which investigated the efficacy of CagriSema for weight loss [1] Group 1: Trial Results - The "REDEFINE 1" trial showed that patients treated with CagriSema experienced a weight loss of 22.7% after 68 weeks, falling short of the company's target of at least 25% [1] - Only 57.3% of patients in the trial were on the highest dosage of CagriSema, as participants were allowed to modify their own dosage during the trial [1] Group 2: Stock Price Impact - Following the announcement of the trial results, Novo's stock price decreased by $18.44 per share, closing at $85.00 per share [1] Group 3: Class Action Information - Shareholders who purchased shares of NVO during the class period from November 2, 2022, to December 19, 2024, are encouraged to register for a class action lawsuit [2] - The deadline for shareholders to seek lead plaintiff status is March 25, 2025, and there is no cost or obligation to participate in the case [2]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of ESSA Pharma Inc. regarding a class action lawsuit due to alleged misleading statements related to the efficacy of masofaniten in combination with enzalutamide for prostate cancer treatment [1][2]. Group 1: Allegations - The complaint alleges that during the class period from December 12, 2023, to October 31, 2024, the defendants made materially false and misleading statements about masofaniten's efficacy [2]. - It is claimed that masofaniten in combination with enzalutamide did not demonstrate a clear efficacy benefit over enzalutamide alone, contrary to what was communicated to investors [2]. - The M-E Combination Study was unlikely to meet its prespecified Phase 2 primary endpoint, indicating that the clinical and commercial prospects of masofaniten were overstated [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is March 25, 2025, and they are encouraged to register without delay [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. - There is no cost or obligation for shareholders to participate in this class action [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and fraud [4]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].